Newsroom
Sorted by: Latest
-
Resumen: Aptiv impulsa aplicaciones inteligentes vanguardistas, desde la automoción hasta la robótica, en el CES 2026
SCHAFFHAUSEN, Suiza--(BUSINESS WIRE)--Aptiv PLC (NYSE: APTV), sociedad global de tecnología industrial, mostrará en el CES 2026 cómo sus soluciones inteligentes permiten a distintos dispositivos detectar, pensar y actuar en tiempo real, además de optimizar continuamente el rendimiento a lo largo de su ciclo de vida. Este planteamiento acerca la informática avanzada y la inteligencia artificial al lugar donde se generan los datos, abriendo así las puertas a soluciones basadas en la IA para el tr...
-
Samenvatting: Samsung Bioepis start met de verkoop in Europa van BYOOVIZ®, een biosimilar van Lucentis (ranibizumab)
INCHEON, Korea--(BUSINESS WIRE)--Samsung Bioepis Co., Ltd. heeft vandaag bekendgemaakt dat het bedrijf is begonnen met de directe verkoop van BYOOVIZ®, een biosimilar van Lucentis1 (ranibizumab), in Europa. Samsung Bioepis heeft gewerkt aan een naadloze overdracht van de commerciële rechten van Biogen terug naar Samsung Bioepis. BYOOVIZ zal nu in meerdere Europese landen verkrijgbaar zijn als merk van Samsung Bioepis. Deze bekendmaking is officieel geldend in de originele brontaal. Vertalingen...
-
KALEON : MISE EN ŒUVRE D’UN CONTRAT DE LIQUIDITE AVEC TP ICAP EUROPE SA
MILAN--(BUSINESS WIRE)--Regulatory News: Kaleon S.p.A. (« Kaleon » ou la « Société ») (Paris:ALKLN) (MIL:KLN) – société détenue par la famille Borromeo spécialisée dans la valorisation, la préservation et la conservation du patrimoine historique et artistique italien et international, annonce avoir confié à TP ICAP Europe SA la mise en œuvre d’un contrat de liquidité portant sur ses actions ordinaires admises aux négociations sur Euronext Growth Paris. Ce contrat est conclu pour une durée d'un...
-
Pershing Square Holdings, Ltd. UK Regulatory Announcement: Net Asset Value(s)
LONDON--(BUSINESS WIRE)-- Pershing Square Holdings, Ltd. Releases Monthly Net Asset Value and Performance Report for December 2025 Pershing Square Holdings, Ltd. (LN:PSH) (LN:PSHD) today released the following regular monthly Net Asset Value (NAV) and Performance Report for the month of December 2025. The information has also been posted to the PSH website, www.pershingsquareholdings.com. Monthly net asset value and performance are calculated at the close of business on the last business day o...
-
Kosmos Energy Provides Operational and Financial Update
DALLAS--(BUSINESS WIRE)--Kosmos Energy (NYSE/LSE: KOS) (“Kosmos” or the “Company”) today provided an operational and financial update on its recent business activities. Operational Update In Ghana, the second producer well (J-74) in the 2025-2026 Jubilee field development campaign has been successfully drilled and completed, and is expected online shortly. The well encountered approximately 50 meters of net pay, in line with Kosmos’ expectations and has been completed in three zones, similar to...
-
Pershing Square Holdings, Ltd. UK Regulatory Announcement: Transaction in Own Shares
LONDON--(BUSINESS WIRE)-- Pershing Square Holdings, Ltd. Announces Transactions in Own Shares - 2 January 2026 Pershing Square Holdings, Ltd. (LN:PSH) (LN:PSHD) (“PSH”) today announced that it has purchased, through PSH’s agent, Jefferies International Limited (“Jefferies”), the following number of PSH’s Public Shares of no par value (ISIN Code: GG00BPFJTF46) (the "Shares"): Total Buyback Ticker/s: PSH (LSE); PSHD (LSE) Date of Purchase: 2 January 2026 Number of Public Shares Purchased: 18,2...
-
Samsung Bioepis commence la commercialisation de BYOOVIZ®, médicament biosimilaire du Lucentis (ranibizumab), en Europe
INCHEON, Corée--(BUSINESS WIRE)--Samsung Bioepis Co., Ltd. a annoncé aujourd’hui avoir commencé la commercialisation directe de BYOOVIZ®, un médicament biosimilaire du Lucentis1 (ranibizumab), en Europe. Samsung Bioepis s’est efforcé d’assurer un transfert sans heurts des droits commerciaux de Biogen à Samsung Bioepis et BYOOVIZ sera désormais disponible sous la marque Samsung Bioepis dans plusieurs pays européens. « Il s’agit d’une étape importante pour Samsung Bioepis, qui continue de renforc...
-
Aptiv Powers Intelligent Edge Applications From Automotive to Robotics at CES 2026
SCHAFFHAUSEN, Switzerland--(BUSINESS WIRE)--Aptiv PLC (NYSE: APTV), a global industrial technology company, will showcase at CES 2026 how its intelligent edge solutions enable devices to sense, think, and act in real time—while continuously optimizing performance throughout their lifecycle. This approach brings advanced computing and artificial intelligence closer to where data is generated, unlocking AI-driven solutions for transportation, robotics, aerospace, and beyond. By processing data lo...
-
Elliptic Labs Ships Seven Smartphone Models with vivo and HONOR for December 2025
OSLO, Norway--(BUSINESS WIRE)--Elliptic Labs is announcing that it has shipped the AI Virtual Smart Sensor Platform™ on seven smartphone models in December 2025....
-
基于MediaTek全球首款5G-A平台,移远通信率先推出车规级5G R18模组AR588MA
SHANGHAI--(BUSINESS WIRE)--(美国商业资讯)-- 1月4日,在2026年国际消费电子产品展览会 (CES 2026) 前夕,全球领先的物联网和车联网整体解决方案供应商移远通信宣布,率先推出其符合3GPP R18标准的车规级5G-A模组AR588MA。 该系列模组基于MediaTek全球首款5G-A平台MT2739打造,实现了全域信号覆盖、高速连接传输、AI智能网络适配及车规级安全保障四大核心突破,为下一代智能网联汽车的创新发展提供强劲支撑。目前,该模组可对外提供工程样品,已有多家头部车企启动 AR588MA 系列的方案导入工作。 移远通信汽车前装事业部总经理王敏表示:“5G-A技术在车载领域的落地应用,精准匹配了下一代智能汽车对超大带宽、超低时延与极致可靠性的核心诉求。此次发布的AR588MA,凭借多重技术优势,可充分适配高阶辅助驾驶、车载智能交互、车路协同等关键场景,为全球智能网联汽车产业升级筑牢通信根基。” “地面+卫星”全覆盖,高速传输更可靠 作为基于MediaTek首款5G-A平台的车规级模组,AR588MA系列模组的Modem(调制解调器)性能达到业...